✦ LIBER ✦

Primary debulking surgery or neoadjuvant chemotherapy: What is the optimal treatment approach for obese patients with ovarian/fallopian tube/primary peritoneal carcinoma?

✍ Scribed by Worley, M.J.; Guseh, S.; Rauh-Hain, J.A.; Esselen, K.M.; Muto, M.G.; Feltmate, C.; Berkowitz, R.S.; Del Carmen, M.G.; Schorge, J.O.; Horowitz, N.S.

Book ID: 127285239
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 53 KB
Volume: 133
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2014.03.088

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of an Open-Label Study to Evalua

Results of an Open-Label Study to Evaluate the Efficacy and Tolerability of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting Associated with Carboplatin-Containing Chemotherapy in Patients with Ovarian Cancer, Primary Peritoneal, or Fallopian Tube Carcinoma (Stage I-IV) or Papillary Serous Cancer of the Uterus

✍ Patrick Timmins III; Daniel Kredentser; Kenneth Hancock; Mark Messing; Kristi A. 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 104 KB